Fig. 4.
Phosphorylation of MBP by mDYRK-3 and apparent autophosphorylation in 293 fibroblasts.
To initially assess catalytic activity, mDYRK-3 (and the type II subdomain mutant mDYRK-3–K202R) were expressed transiently as Myc epitope–tagged constructs in 293 cells. At 48 hours posttransfection, mAb 9E10 immunoprecipitates were prepared from whole-cell lysates and were used together with 32P γATP plus MBP or histone 2B (H2B) in in vitro kinase assays. Shown in the upper panel are electrophoresed and autoradiographed 32P products. Immunoprecipitates were also eluted, and epitope-tagged wild-type mDYRK-3 and mDYRK-3–K202R were assayed by Western blotting (lower panel). Indexed are 2 forms of mDYRK-3 (ie, molecular-weight 68 000 and 70 000 forms), and the positions of molecular-weight standards.